Content about Health & Wellness

April 13, 2011

The National Association of Chain Drug Stores said that it has signed on as a partner for a new public-private partnership, announced by the Department of Health and Human Services and Centers for Medicare & Medicaid Services, that seeks to improve patient health and lower healthcare costs through the use of community-based care transition programs.

ALEXANDRIA, Va. — The National Association of Chain Drug Stores said that it has signed on as a partner for a new public-private partnership, announced by the Department of Health and Human Services and Centers for Medicare & Medicaid Services, that seeks to improve patient health and lower healthcare costs through the use of community-based care transition programs.

NACDS lauded the initiative's recognition of pharmacy's role in helping patients take their medications as prescribed.

April 13, 2011

The National Community Pharmacists Association on Wednesday announced support for the Quality Health Care Coalition Act of 2011 (H.R. 1409), which was introduced last week by House Judiciary Committee ranking member Rep. John Conyers Jr., D-Mich., and Rep. Ron Paul, R-Texas, in an effort to improve the quality of patient care by leveling the playing field between healthcare professionals and insurance companies in the healthcare industry.

ALEXANDRIA, Va. — The National Community Pharmacists Association on Wednesday announced support for the Quality Health Care Coalition Act of 2011 (H.R. 1409), which was introduced last week by House Judiciary Committee ranking member Rep. John Conyers Jr., D-Mich., and Rep. Ron Paul, R-Texas, in an effort to improve the quality of patient care by leveling the playing field between healthcare professionals and insurance companies in the healthcare industry.

April 12, 2011

The 2011 allergy season is expected to be 27 days longer in the northernmost parts of North America, adding almost a month of suffering to the typical pollen allergy season of February through October, a study published Tuesday by the Proceedings of the National Academy of Sciences determined.

JACKSONVILLE, Fla. — The 2011 allergy season is expected to be 27 days longer in the northernmost parts of North America, adding almost a month of suffering to the typical pollen allergy season of February through October, a study published Tuesday by the Proceedings of the National Academy of Sciences determined.

April 12, 2011

Medication adherence among hepatitis C patients may improve when patients take antidepressants, according to a new analysis by pharmacy benefit manager Medco Health Solutions presented Monday at the International Conference on Viral Hepatitis.

BALTIMORE — Medication adherence among hepatitis C patients may improve when patients take antidepressants, according to a new analysis by pharmacy benefit manager Medco Health Solutions presented Monday at the International Conference on Viral Hepatitis.

April 12, 2011

Infopia America last week announced that its new SmartDiabetes product line has launched in 284 Walgreens drug stores in central and northeast Florida. The central Florida Walgreens region includes stores in Jacksonville, Orlando, Lakeland, Daytona Beach and Melbourne.

TITUSVILLE, Fla. — Infopia America last week announced that its new SmartDiabetes product line has launched in 284 Walgreens drug stores in central and northeast Florida. The central Florida Walgreens region includes stores in Jacksonville, Orlando, Lakeland, Daytona Beach and Melbourne.

April 12, 2011

The utilization of specialty pharmacy is projected to steadily increase, Walgreens VP clinical affairs David Lorber told attendees Tuesday at the Pinsonault Associates Managed Markets Summit, which accentuates a need to augment patient compliance and help payers get a handle on what have become rapidly shifting economics.

MIAMI — The utilization of specialty pharmacy is projected to steadily increase, Walgreens VP clinical affairs David Lorber told attendees Tuesday at the Pinsonault Associates Managed Markets Summit, which accentuates a need to augment patient compliance and help payers get a handle on what have become rapidly shifting economics.

April 12, 2011

A diabetes education program developed by Johns Hopkins researchers significantly improved long-term blood-sugar control among patients.

NEW YORK — A diabetes education program developed by Johns Hopkins researchers significantly improved long-term blood-sugar control among patients.

April 12, 2011

A point-of-sale safety check may reduce the risk of patients unsafely receiving a drug for Type 2 diabetes that may increase their risk of heart attack, according to a new study conducted by pharmacy benefit manager Prime Therapeutics and scheduled for presentation at the 23rd annual meeting of the Academy of Managed Care Pharmacy in Minneapolis.

ST. PAUL, Minn. — A point-of-sale safety check may reduce the risk of patients unsafely receiving a drug for Type 2 diabetes that may increase their risk of heart attack, according to a new study conducted by pharmacy benefit manager Prime Therapeutics and scheduled for presentation at the 23rd annual meeting of the Academy of Managed Care Pharmacy in Minneapolis.

April 12, 2011

The Food and Drug Administration has approved a treatment made by Merck for treating skin cancer, Merck said Monday.

WHITEHOUSE STATION, N.J. — The Food and Drug Administration has approved a treatment made by Merck for treating skin cancer, Merck said Monday.

Merck announced the approval of Sylatron (peginterferon alfa-2b) as an add-on treatment for treating melanoma with microscopic of gross nodal involvement within 84 days of surgery.

April 12, 2011

An investigational drug made by Teva Pharmaceutical Industries and Active Biotech for multiple sclerosis reduced disease relapses and prevented the progression of disability, according to late-stage clinical trial results announced Monday.

JERUSALEM — An investigational drug made by Teva Pharmaceutical Industries and Active Biotech for multiple sclerosis reduced disease relapses and prevented the progression of disability, according to late-stage clinical trial results announced Monday.

April 11, 2011

Celebrity chef Curtis Stone has been tapped for the latest Post Great Grains cereal campaign to show how the consumption of whole grains can lead to better nutrition.

PARSIPPANY, N.J. — Celebrity chef Curtis Stone has been tapped for the latest Post Great Grains cereal campaign to show how the consumption of whole grains can lead to better nutrition.

April 11, 2011

Endo Pharmaceuticals will buy American Medical Systems for $2.9 billion, the drug maker said Monday.

CHADDS FORD, Pa. — Endo Pharmaceuticals will buy American Medical Systems for $2.9 billion, the drug maker said Monday.

Endo said it and AMS had reached an agreement whereby Endo would acquire the maker of devices and therapies for pelvic health for $30 per share. AMS’ business focuses on men’s health, women’s health and benign prostatic hyperplasia.

April 11, 2011

ConAgra is emphasizing the use of its Healthy Choice frozen meals to improve the quality of one's diet and overall well-being.

OMAHA, Neb. — ConAgra is emphasizing the use of its Healthy Choice frozen meals to improve the quality of one's diet and overall well-being.

April 11, 2011

The Food and Drug Administration has approved a drug made by Johnson & Johnson for treating schizophrenia in adolescents.

TITUSVILLE, N.J. — The Food and Drug Administration has approved a drug made by Johnson & Johnson for treating schizophrenia in adolescents.

J&J said Monday that the FDA had approved Invega (paliperidone) extended-release tablets for patients ages 12 to 17 years. The drug is marketed by J&J subsidiary Ortho-McNeil-Janssen Pharmaceuticals. The drug originally was approved in 2006 for treating schizophrenia in adults.

April 11, 2011

A drug originally developed by scientists in the Soviet Union to treat allergies and currently under investigation by Pfizer and Medivation did not yield significant results in a late-stage clinical trial of patients with Huntington disease, a disorder that leads to cognitive decline, the companies said Monday.

NEW YORK — A drug originally developed by scientists in the Soviet Union to treat allergies and currently under investigation by Pfizer and Medivation did not yield significant results in a late-stage clinical trial of patients with Huntington disease, a disorder that leads to cognitive decline, the companies said Monday.

April 11, 2011

The Food and Drug Administration has approved an oral contraceptive made by Sandoz, the company said Friday.

PRINCETON, N.J. — The Food and Drug Administration has approved an oral contraceptive made by Sandoz, the company said Friday.

Sandoz, the generics division of Swiss drug maker Novartis, announced the approval of Altavera (levonorgestrel and ethinyl estradiol) tablets, a generic version of Duramed’s Nordette.

Branded and generic versions of Nordette had sales of about $57.4 million during the 12-month period ended in February, according to IMS Health.

April 11, 2011

Winn-Dixie on Monday announced that its pharmacy will offer specially designed medication disposal envelopes to help its customers safely dispose of unused, outdated or unwanted medications.

JACKSONVILLE, Fla. — Winn-Dixie on Monday announced that its pharmacy will offer specially designed medication disposal envelopes to help its customers safely dispose of unused, outdated or unwanted medications.

The specially designed TakeAway Environmental Return System envelopes, made by Sharps Compliance, offer a convenient, safe and environmentally responsible method to dispose of unused, expired or unwanted noncontrolled prescription or over-the-counter medications, the grocer stated.

April 8, 2011

The Department of Health and Human Services on Friday launched two plans aimed at reducing health disparities.

WASHINGTON — The Department of Health and Human Services on Friday launched two plans aimed at reducing health disparities.

“For the first time, the United States has a coordinated road map designed to give everyone the chance to live a healthy life,” stated HHS secretary Kathleen Sebelius. “We all need to work together to combat this persistent problem so that we can build healthier communities and a stronger nation.”

April 8, 2011

Supermarket chain Hy-Vee has brought in Australian-born celebrity chef Curtis Stone to develop recipes designed to put the fun in cooking at home, the company said Friday.

WEST DES MOINES, Iowa — Supermarket chain Hy-Vee has brought in Australian-born celebrity chef Curtis Stone to develop recipes designed to put the fun in cooking at home, the company said Friday.

Stone, the host of “Top Chef Masters” on Bravo and an investor and mentor on NBC’s “America’s Next Great Restaurant,” will be featured in the chain’s television commercials, print ads and in-store marketing materials for the next two years.

April 8, 2011

Impax Labs will collaborate with a specialty pharmaceutical company dedicated to the research, development and manufacturing of unique gelatin-based dosage forms.

HAYWARD, Calif., and HIGH POINT, N.C. — Impax Labs will collaborate with a specialty pharmaceutical company dedicated to the research, development and manufacturing of unique gelatin-based dosage forms.

Impax said it has entered a deal with Banner Pharmacaps in respect to the supply and commercialization of two softgel capsule products.

The products and terms of the agreement were not disclosed.

April 8, 2011

A Georgetown University Health Policy Institute study of Florida’s Medicaid Managed Care pilot program should raise doubts for states considering the use of for-profit managed care companies to reduce Medicaid costs, the National Community Pharmacists Association cautioned on Friday.

ALEXANDRIA, Va. — A Georgetown University Health Policy Institute study of Florida’s Medicaid Managed Care pilot program should raise doubts for states considering the use of for-profit managed care companies to reduce Medicaid costs, the National Community Pharmacists Association cautioned on Friday.

April 8, 2011

Nine people died in Alabama last month after taking a compounded injectable supplement contaminated with bacteria, according to published reports.

NEW YORK — Nine people died in Alabama last month after taking a compounded injectable supplement contaminated with bacteria, according to published reports.

The New York Times reported that the patients died of infections with Serratia marcescens bacteria in hospitals after receiving the intravenously administered supplement total parenteral nutrition from the Birmingham, Ala.-based compounding pharmacy Meds IV Pharmacy.

April 8, 2011

Watson announced that its subsidiary is seeking approval to market a generic version of a bacterial conjunctivitis treatment.

PARSIPPANY, N.J. — Watson announced that its subsidiary is seeking approval to market a generic version of a bacterial conjunctivitis treatment.

Watson Labs filed an abbreviated new drug application with the Food and Drug Administration for moxifloxacin hydrochloride ophthalmic solution USP in the 0.5% strength. The antibiotic solution is a generic version of Alcon's Vigamox, which had total U.S. sales of about $281 million ended in February, according to IMS Health.

April 7, 2011

In anticipation of Earth Day 2011 on April 22, the National Community Pharmacists Association is encouraging community pharmacists to demonstrate their role as a respected and knowledgeable resource on all aspects of medications, from dispensing to disposal, the association announced Thursday.

ALEXANDRIA, Va. — In anticipation of Earth Day 2011 on April 22, the National Community Pharmacists Association is encouraging community pharmacists to demonstrate their role as a respected and knowledgeable resource on all aspects of medications, from dispensing to disposal, the association announced Thursday.

April 7, 2011

The Food and Drug Administration has approved a drug made by AstraZeneca for treating a rare form of thyroid cancer, the agency said.

SILVER SPRING, Md. — The Food and Drug Administration has approved a drug made by AstraZeneca for treating a rare form of thyroid cancer, the agency said.

The FDA announced the approval of the daily pill vandetanib for late-stage medullary thyroid cancer in patients whose disease is growing and causing symptoms but who are ineligible for surgery.

Medullary thyroid cancer involves specific cells found in the thyroid gland and can occur spontaneously or be part of a genetic disease. There currently are no FDA-approved treatments for this cancer.